Autoimmune Pancreatitis Clinical Trial
| NCT number | NCT01774513 |
| Other study ID # | 1212013 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | January 22, 2013 |
| Last updated | January 22, 2013 |
| Start date | January 2013 |
The goal of this prospective study is to evaluate the feasibility of the Core Biopsy Needle with reverse bevel (Procore TM) in diagnosing autoimmune pancretitis
| Status | Recruiting |
| Enrollment | 16 |
| Est. completion date | |
| Est. primary completion date | December 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - patient age 18 years and older - patients with suspicion of autoimmune pancreatitis (based on the findings in EUS and MRI) Exclusion Criteria: - unable to obtain informed consent - ASA class 4 and 5 - known pregnancy - contraindication for endoscopy or for biopsy sampling - patients with high suspicion on pancreatic cancer (based on the findings in radiology and EUS) |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Country | Name | City | State |
|---|---|---|---|
| Germany | Klinikum rechts der Isar | Munich | Bavaria |
| Lead Sponsor | Collaborator |
|---|---|
| Technische Universität München |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | diagnostic yield | Number of patients with adequate tissue sample (which allows definitive diagnosis) | 6 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03753815 -
Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune Pancreatitis
|
N/A | |
| Recruiting |
NCT02797665 -
Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
|
N/A | |
| Recruiting |
NCT04834505 -
To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
|
||
| Recruiting |
NCT04397731 -
Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune Pancreatitis
|
||
| Not yet recruiting |
NCT06358001 -
EchoTip AcuCore Post-Market Clinical Study
|
||
| Completed |
NCT05476978 -
Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
|
||
| Recruiting |
NCT06369909 -
Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
|
||
| Completed |
NCT03241797 -
Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis
|
N/A | |
| Completed |
NCT05171517 -
Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
|
||
| Withdrawn |
NCT01845467 -
Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
|
||
| Completed |
NCT05565066 -
A Real-world Comparison of FNB and FNA in IHC-required Lesions.
|
||
| Completed |
NCT02705638 -
Treatment of IgG4-Related Disease With Revlimid and Rituximab
|
Phase 1 | |
| Withdrawn |
NCT02766842 -
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)
|
Phase 2 | |
| Completed |
NCT01584388 -
Rituximab in IgG4-related Disease: A Phase 1-2 Trial
|
Phase 1/Phase 2 | |
| Completed |
NCT00588367 -
CT Pancreas Perfusion
|
N/A |